Hospira Docetaxel Injection, 120 mg/12 mL, single vial

Country: Awstralja

Lingwa: Ingliż

Sors: Department of Health (Therapeutic Goods Administration)

Ingredjent attiv:

docetaxel, Quantity: 10 mg/mL

Disponibbli minn:

Hospira Australia Pty Ltd

INN (Isem Internazzjonali):

Docetaxel

Għamla farmaċewtika:

Injection

Kompożizzjoni:

Excipient Ingredients: citric acid; ethanol absolute; polysorbate 80; polyethylene glycol monomethyl ether

Rotta amministrattiva:

Intravenous Infusion

Unitajiet fil-pakkett:

1 x 15 mL vial

Tip ta 'preskrizzjoni:

(S1) This Schedule is intentionally blank

Indikazzjonijiet terapewtiċi:

Breast cancer, Non-small cell lung cancer, Stomach cancer, Head and neck cancer, Ovarian cancer, Oesophageal cancer, Uterine cancer, Prostate cancer

Sommarju tal-prodott:

Visual Identification: A clear, colourless to pale yellow solution; Container Type: Vial; Container Material: Glass Type I Clear; Container Life Time: 2 Years; Container Temperature: Room temperature; Container Closure: Neither child resistant closure nor restricted flow insert

L-istatus ta 'awtorizzazzjoni:

Licence status A

Data ta 'l-awtorizzazzjoni:

2013-10-25